Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
duration is available in the research group Cellular Membrane Dynamics, led by prof. Harald Stenmark at Centre for Cancer Cell Reprogramming (CanCell), Institute of Clinical Medicine. The group is located
-
. The main focus areas include cancer research, physiology, neuroscience, drug discovery, metabolism, disease mechanisms, proteomics, biomarkers, cardiovascular research, the relationship between structure and
-
: ForestFeed - A Nordic blue-green value chain from forest to fish filet. This project aims to establish sustainable production of microbial feed ingredients (PEKILO®) by biotransformation of locally available
-
of the Protein Engineering and Proteomics (PEP) group, with connections to the NMBU Nitrogen-group. By examining the intricate breakdown of plant material under denitrifying conditions in freshwater
-
-source parameters including imaging, proteomic and genomic data as well as life-style patient data from wearables to enable personalised vascular disease management. The VASCUL-AID platform consists of AI
-
trustworthy AI-driven platform (VASCUL-AID) that integrates multi-source parameters including imaging, proteomic and genomic data as well as life-style patient data from wearables to enable personalised
-
areas include cancer research, physiology, neuroscience, drug discovery, metabolism, disease mechanisms, proteomics, biomarkers, cardiovascular research, the relationship between structure and function
-
(for instance from watches and phones), self-reported patient data, and omics data from tissue analyses (genomics, transcriptomics, proteomics, etc.). When such data are compiled for an individual, one may be
-
-reported patient data, and omics data from tissue analyses (genomics, transcriptomics, proteomics, etc.). When such data are compiled for an individual, one may be able to develop therapeutic tools
-
samples to laboratory based investigation of vascular cell behaviour. Part of our research group are based at Karolinska Institute/KTH Royal Institute of Technology, Stockholm, Sweden, with the opportunity